A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/425 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 31/44 (2006.01) A61K 31/4439 (2006.01)
Patent
CA 2338216
A method for reducing post-ischaemic injury of the heart and/or improving the functional recovery of the heart following myocardial ischaemia which method comprises administration of an effective, non-toxic amount of a glucose uptake enhancer to a human or non-human mammal in need thereof.
L'invention se rapporte à un procédé de réduction des lésions cardiaques d'origine ischémique et/ou d'amélioration de la récupération fonctionnelle du coeur à la suite d'une ischémie myocardique. Ledit procédé consiste en l'administration d'une quantité efficace, non toxique, d'un activateur d'assimilation du glucose à un mammifère humain ou non humain nécessitant un tel traitement.
Bril Antoine Michel Alain
Buckingham Robin Edwin
Khandoudi Nassirah
Gowling Lafleur Henderson Llp
Smithkline Beecham Laboratoires Pharmaceutiques
Smithkline Beecham P.l.c.
LandOfFree
Use of glucose uptake enhancer for reducing post-ischemic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of glucose uptake enhancer for reducing post-ischemic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of glucose uptake enhancer for reducing post-ischemic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2042792